The slip
PARKINSON RECEIPTno. 4651
20 Oct 2026, 22:20 UTCdopamine neurons, braak
predictionCHD7 in dopamine neurons tracks Braak Lewy-body stage
registered285c4501f32629c9
discovery-0.32 p=0.402 n=9
replication+0.45 p=0.222 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.32, p 0.402)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT26bb3720675d01d2f0622914…
follows 47e064c429e7…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4651: CHD7 in dopamine neurons, braak
- power
- full sample -0.03 (p 0.901, n 18), 95% CI -0.49 to +0.44. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.01 (p 0.956, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.06 (p 0.807, n 18). could be the mix.
- skeptic
- leave-one-out range -0.11 to +0.12, sign flips 4; without severely affected donors -0.03 (p 0.901, n 18). fragile.
- cell type
- strongest in OPCs: +0.60 (p 0.0083, n 18) vs -0.03 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for CHD7 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up CHD7 · OPCs · braak: substantia nigra, an independent cohort (already registered)